However, human SHH subtype and mouse Ptch1Δ/+ medulloblastomas arise as a consequence of SHH ligand-independent activation of signal transduction due to mutations in and/or inactivation of Ptch1 and downstream effectors (see above). The gene discussed is SHH; the disease is medulloblastoma.